Lanzamiento Enero 2027

Estudio de cohortes2021Acceso abierto

Eicosapentaenoic Acid Is Associated with Decreased Incidence of Alzheimer's Dementia in the Oldest Old

Melo van Lent D, Egert S, Wolfsgruber S, Kleineidam L, Weinhold L, Wagner-Thelen H, Maier W, Jessen F, Ramirez A, Schmid M, Scherer M, Riedel-Heller SG, Wagner M

Nutrients · 29 citas

Cómo se estudió

Diseño
Estudio de cohortes (indexado por PubMed)
Estudiado en
Personas
Resultado principal
Eventos clínicos como enfermedad o muerte

Quién lo pagó

Financiación
Financiación independiente
Organización sin fines de lucro
Alzheimer Forschung Initiative
Gobierno
Bundesministerium für Bildung und Forschung
Subvenciones
Bundesministerium für Bildung und Forschung (01GI0102); Bundesministerium für Bildung und Forschung (01EA1372D); Bundesministerium für Bildung und Forschung (01GY1322D); Bundesministerium für Bildung und Forschung (01GI0715); Bundesministerium für Bildung und Forschung (01GI0429); Bundesministerium für Bildung und Forschung (01GI0434); Bundesministerium für Bildung und Forschung (01GI0423); Bundesministerium für Bildung und Forschung (01GI0422); Bundesministerium für Bildung und Forschung (01GY1322A, 01GY1322B, 01GY1322C, 01GY1322D, 01GY1322E, 01GY1322F, 01GY1322G); Bundesministerium für Bildung und Forschung (01GY1322B); Bundesministerium für Bildung und Forschung (01GY1322C); Bundesministerium für Bildung und Forschung (01EA1410C); Bundesministerium für Bildung und Forschung (01GI0712); Bundesministerium für Bildung und Forschung (01GY1322F); Bundesministerium für Bildung und Forschung (01GI0711); Bundesministerium für Bildung und Forschung (01GI0716); Bundesministerium für Bildung und Forschung (01GI0431); Bundesministerium für Bildung und Forschung (01GI0713); Bundesministerium für Bildung und Forschung (01GI0420); Bundesministerium für Bildung und Forschung (01GI0710); Bundesministerium für Bildung und Forschung (01GI0714); Bundesministerium für Bildung und Forschung (01GY1322E); Bundesministerium für Bildung und Forschung (01GI0433); Bundesministerium für Bildung und Forschung (01GY1322G); Bundesministerium für Bildung und Forschung (01GI0710, 01GI0711, 01GI0712, 01GI0713, 01GI0714, 01GI0715, 01GI0716); Bundesministerium für Bildung und Forschung (01GY1322A)

Según 2 financiadores declarados y la declaración de financiación del texto completo.

Publicación

Publicado
2021-01-30 · Nutrients · vol. 13 · número 2 · pág. 461
Editorial
Multidisciplinary Digital Publishing Institute
Citado
43 citas · más que el 92% de estudios similares · 3.1× el promedio de su campo
Impacto
Entre el 10 % más citado de su campo
Referencias
70 trabajos
Acceso
Acceso abierto (revista) · CC-BY
Áreas de investigación
Fatty Acid Research and Health · Nutritional Studies and Diet · Eicosanoids and Hypertension Pharmacology
Palabras clave
Eicosapentaenoic acid, Dementia, Docosahexaenoic acid, Polyunsaturated fatty acid, Arachidonic acid, Medicine, Internal medicine, Hazard ratio, Cognitive decline, Linoleic acid, Omega 3 fatty acid, Vascular dementia, Gastroenterology, Fatty acid, Disease, Biochemistry, Biology, Confidence interval
MeSH
humans, dementia, alzheimer disease, fatty acids, omega-3, eicosapentaenoic acid, fatty acids, fatty acids, unsaturated, fatty acids, omega-6, phospholipids, activities of daily living, incidence, proportional hazards models, longitudinal studies, prospective studies, aged, 80 and over, germany, female, male

13 autores

  • Debora Melo van Lent🇺🇸🇩🇪 · autor de correspondenciaThe University of Texas at San Antonio Health Science Center; German Center for Neurodegenerative Diseases; Institute for Neurodegenerative Disorders
  • Sarah Egert🇩🇪University of Hohenheim
  • Steffen Wolfsgruber🇩🇪University Hospital Bonn; German Center for Neurodegenerative Diseases
  • Luca Kleineidam🇩🇪University Hospital Bonn
  • Leonie Weinhold🇩🇪University Hospital Bonn; Zimmer Biomet (Germany)
  • Holger Wagner-Thelen🇩🇪University Hospital Bonn
  • Wolfgang Maier🇩🇪University Hospital Bonn
  • Frank Jessen🇩🇪University of Cologne; German Center for Neurodegenerative Diseases
  • Alfredo Ramı́rez🇩🇪University of Cologne; German Center for Neurodegenerative Diseases
  • Matthias C. Schmid🇩🇪University Hospital Bonn; German Center for Neurodegenerative Diseases; Zimmer Biomet (Germany)
  • Martin Scherer🇩🇪Universität Hamburg; University Medical Center Hamburg-Eppendorf
  • Steffi Gerlinde Riedel-Heller🇩🇪Leipzig University
  • Michael Wagner🇩🇪University Hospital Bonn; German Center for Neurodegenerative Diseases

Resumen

El texto original del estudio, en el idioma en que se publicó.

Background

Omega-3 (n-3) and omega-6 (n-6) polyunsaturated fatty acids (PUFAs) may have different effects on cognitive health due to their anti- or pro-inflammatory properties.

Methods

We aimed to prospectively examine the relationships between n-3 and n-6 PUFA contents in serum phospholipids with incident all-cause dementia and Alzheimer's disease dementia (AD). We included 1264 non-demented participants aged 84 ± 3 years from the German Study on Ageing, Cognition, and Dementia in Primary Care Patients (AgeCoDe) multicenter-cohort study. We investigated whether fatty acid concentrations in serum phospholipids, especially eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA), alpha-linolenic acid (ALA), linoleic acid (LA), dihomo-γ-linolenic acid (DGLA), and arachidonic acid (AA), were associated with risk of incident all-cause dementia and AD.

Results

During the follow-up window of seven years, 233 participants developed dementia. Higher concentrations of EPA were associated with a lower incidence of AD (hazard ratio (HR) 0.76 (95% CI 0.63; 0.93)). We also observed that higher concentrations of EPA were associated with a decreased risk for all-cause dementia (HR 0.76 (95% CI 0.61; 0.94)) and AD (HR 0.66 (95% CI 0.51; 0.85)) among apolipoprotein E ε4 (APOE ε4) non-carriers but not among APOE ε4 carriers. No other fatty acids were significantly associated with AD or dementia.

Conclusions

Higher concentrations of EPA were associated with a lower risk of incident AD. This further supports a beneficial role of n-3 PUFAs for cognitive health in old age.

Resumen vía Europe PMC. Los derechos de autor siguen siendo de los autores o la editorial (CC BY).

Confianza de la comunidad

Cargando…

¿Cuánto confías en los hallazgos de este estudio?

0 · nada10 · totalmente

Comentarios

¿Algo está mal aquí?

Señala este estudio si su información, etiquetas o financiación parecen incorrectas. Un editor revisa cada señalamiento.

Información educativa sobre investigación publicada. No es consejo médico ni una recomendación para empezar o dejar nada.